Study S002611

Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07175805
Study type: OBSERVATIONAL
Status: NOT_YET_RECRUITING
Enrollment: 200
Start: 2025-10
Primary completion: 2026-10
Lead sponsor: Hartford HealthCare
Conditions: Lower Urinary Tract Symptoms; Stress Urinary Incontinence; Urge Urinary Incontinence; Overactive Bladder; Pelvic Organ Prolapse; Weight Loss; Fecal Incontinence; Bariatric Surgery; glp1 Agonist
Interventions: PROCEDURE:Bariatric Surgery; DRUG:GLP1 receptor agonist
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in pelvic floor symptoms measured by survey the Urogenital Distress Inventory (UDI) [6 months]
Change in pelvic floor symptoms measured by validated survey the Colorectal-Anal Distress Inventory (CRADI-8). [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.